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Abstract
Genetic engineering can expand the utility of pigs for modeling human diseases, and for developing advanced therapeutic
approaches. However, the inefficient production of transgenic pigs represents a technological bottleneck. Here, we assessed
the hyperactive Sleeping Beauty (SB100X) transposon system for enzyme-catalyzed transgene integration into the embryonic
porcine genome. The components of the transposon vector system were microinjected as circular plasmids into the
cytoplasm of porcine zygotes, resulting in high frequencies of transgenic fetuses and piglets. The transgenic animals
showed normal development and persistent reporter gene expression for.12 months. Molecular hallmarks of transposition
were confirmed by analysis of 25 genomic insertion sites. We demonstrate germ-line transmission, segregation of individual
transposons, and continued, copy number-dependent transgene expression in F1-offspring. In addition, we demonstrate
target-selected gene insertion into transposon-tagged genomic loci by Cre-loxP-based cassette exchange in somatic cells
followed by nuclear transfer. Transposase-catalyzed transgenesis in a large mammalian species expands the arsenal of
transgenic technologies for use in domestic animals and will facilitate the development of large animal models for human
diseases.
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Introduction
The pig is an important model in biomedical research [1–5].
Pigs have been used as models for cardiovascular disease [6],
atherosclerosis [7], wound repair [8], cancer [9], diabetes [10] and
ophthalmological diseases [1]. Porcine physiology, metabolism,
genome organisation, life span and pathology reflect human
pathophysiology much better than small animal models. The
prospect of the pig as a large animal model is further underscored
by the recent completion of a raw draft of the porcine genome
(www.sanger.ac.uk/Projects/S_scrofa). Genetic engineering can
expand the utility of pigs for modeling human diseases [1,4], for
developing and validating novel clinical treatments, or for
providing tissue for xenotransplantation [11]. This requires
translation of the repertoire of genetic tools currently employed
in smaller model organisms to practical use in domestic pigs.
Transgenesis in the pig, most commonly achieved by pronuclear
DNA injection or, alternatively, by somatic cell nuclear transfer
(SCNT), is an inefficient and expensive process hampered by poor
predictability of the patterns and levels of transgene expression
[2,12,13]. After pronuclear DNA-injection into porcine zygotes,
typically only 1% of the treated embryos develop into transgenic
founders [12]. Similarly, SCNT in pigs is encumbered by low
developmental potential of reconstructed embryos, and no more
than 1–3% of reconstructed embryos develop to term [4,14–19].
Only a fraction of gain-of-function transgenic offspring produced
by these methods shows the desired expression patterns of the
transgene, as integration of transgenes occurs randomly in the
genome [20,21]. As a consequence, the transgene may be silenced
by epigenetic mechanisms or may show a variegated expression
pattern in a non-predictable fashion. Currently, detailed screening
of founder animals is the only way to identify animals with suitable
expression patterns. The long generation interval of pigs (nearly
one year) and the high costs of animal housing coupled with the
low efficiency of transgenesis limit a broader application of porcine
genetic engineering.
Class II DNA transposons have been successfully used for
transgenesis and insertional mutagenesis in several invertebrate
models [22]. The discovery of the Sleeping Beauty (SB) transposon
[23] expanded the utility of transposon-based technologies in
vertebrate species. During transposition, a single copy of a gene of
interest flanked by the inverted terminal repeats (ITR) of a
transposon is stably incorporated into the genome by the
enzymatic factor (transposase) of transposition. The drawbacks
of classical methods for transgenesis can be overcome by utilizing
transposase-catalyzed gene delivery, as it increases the efficiency of
chromosomal integration and preferentially favours single-copy
(monomeric) insertion events. Commonly, in vitro synthesized
PLoS ONE | www.plosone.org 1 August 2011 | Volume 6 | Issue 8 | e23573
transposase mRNA is injected together with a plasmid-based
transposon, in some cases both components are delivered as DNA.
Germline transgenesis has been achieved in invertebratae, fish,
frogs, chicken and mammals employing the transposons Minos,
Tol1, Tol2, piggyBac and Sleeping Beauty [24–32]. Pronuclear
injections of a hyperactive version of the SB transposase
(SB100X) were shown to be highly efficient in mice [33]. Recently,
porcine primary cells were transduced with SB plasmids, encoding
antibiotic selection markers, and antibiotic-resistant cells were
successfully employed to generate cloned pigs by SCNT [34,35].
Here, we show that cytoplasmic injection of zygotes with
plasmids encoding both components of the hyperactive SB100X
system is a simple and highly efficient method for porcine
transgenesis without the necessity of an antibiotic selection marker.
This transposon-based technique represents a direct and efficient
route to germline-competent founders to establish transgenic lines
in large animal models.
Results
We explored cytoplasmic injection of covalently closed circular
(ccc)-plasmid constructs [36] to deliver the two components of the
hyperactive Sleeping Beauty (SB100X) transposon system into zygotes
for the generation of transgenic pigs. A plasmid expressing the
SB100X transposase (pCMV-SB100X) and a transposon donor
plasmid carrying a Venus fluorophore driven by the ubiquitous
CAGGS promoter and flanked by heterospecific loxP sites (pT2/
VenusRMCE, Figure S1) were co-injected into the cytoplasm of
porcine zygotes (Fig. 1). Intact zygotes were transferred into the
oviduct of recipient animals, and fetuses from day 30 of gestation
(d30) as well as founders born at term were analysed for their
transgenic status and Venus expression. In addition, germline
transmission of the transposon transgene was assessed.
In all experiments approximately 10 picoliter (pl) of a plasmid
solution (see Table 1 for concentrations) was microinjected directly
into the cytoplasm. Cytoplasmic injection has the advantage that
high-speed centrifugation at 12000–15000 g [12] is not required to
reveal the pronuclei within the opaque porcine zygotes (Fig. 1). In
some cases, zygotes and unintendendly 2-cell embryos were flushed
from the oviduct, then the DNA was injected into one blastomere of
2-cell stage embryos. Previous own studies suggested that transfer of
30–40 microinjected embryos is optimal for the establishment of a
pregnancy in the pig [21]. Thus on days where zygotes and 2-cell
stages were flushed, both stages were injected and groups of optimal
size were pooled and transferred.Three different groups of injection
mixtures were tested (Table 1). In groups A and B different ratios of
pT2/VenusRMCE and pCMV-SB100Xwere injected. In group C,
a mixture of pT2/VenusRMCE plasmid and synthetic SB100X
mRNA was injected, since injection solutions of this composition
had been used successfully before for pronuclear injections in
murine zygotes [33].
Treatment A resulted in 4 transgenic fetuses out of 7, and 5
transgenic piglets out of 12 born (Table 1). In groups B and C no
transgenic fetuses could be recovered, most likely due to reduced
plasmid concentrations and a higher susceptibility of the synthetic
RNA to enzymatic degradation. The transgenic fetuses and piglets
resulting from group A were investigated for phenotype, genotype
and germline transmission.
Phenotypic analysis of the transgenic fetuses by specific
excitation of the Venus fluorophore revealed that almost all cell
types expressed the transgene (Fig. 2). Four fetuses showed Venus
fluorescence in ecto-, endo- and mesodermal organs and
extraembryonal membranes. One fetus showed visible Venus-
fluorescence only in the amnion, but not in the fetus itself. Flow
cytometric analysis of fetal fibroblast cultures revealed distinct
populations of Venus-fluorescent cells (Fig. 2H). One cell culture
(#37-3) appeared to be mosaic, with a highly positive and a
negative cell population (Fig. 2H). Flow cytometric sorting and
PCR genotyping suggested that the Venus-negative population
was non-transgenic. This was confirmed by Southern blotting (see
below, Fig. 3E).
Molecular analysis by Southern blotting and PCR confirmed
that phenotypically positive fetuses carried the Venus-transposon,
but not transposon plasmid backbone sequences (Table S1),
indicating a transposase-dependent integration mechanism. South-
ern blotting with SB100X probes did not result in specific
hybridization signals (Table S1), indicating absence of these
sequences in the fetuses. Only one amnion sample was found to be
positive for the pCMV-SB100X amplicon, suggesting a passive,
non-transposase-mediated integration. Southern blotting with a
Venus-specific probe revealed one integration in fetus #37-5, three
integrations in #37-4, ,five integrations in #37-3 and .10
integrations in fetus #37-2 (Fig. 2I). The copy number of the
integrated transposons correlated with the intensities of Venus
fluorescence as determined by FACS analysis (fluorescence
intensities: #37-2.#37-3.#37-4.#37-5) (Fig. 2H). Cloning
and sequencing of 25 integration sites from fetuses, founders and
their offspring (see below) by splinkerette PCR confirmed specific
SB-catalyzed transposition events at the expected TA target
Figure 1. Injection of ccc-plasmids into the cytoplasm of a
zygote. A) Schematic depiction of cytoplasmic plasmid injection (CPI)
into an opaque zygote. B) Cytoplasmic injection into a porcine zygote.
C) For comparative reasons a pronuclear injection in a porcine zygote is
shown. To reveal the pronuclei, a high speed centrifugation at 12’000–
15’000 g is necessary.
doi:10.1371/journal.pone.0023573.g001
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Figure 2. Venus–transposon expression in tissues of the three germ layers and extraembryonic membranes. Images of selected organs
of F0 transgenic porcine fetuses (d30) derived from cytoplasmic injection of transposon plasmids into zygotes. A–F, specific excitation of the Venus
fluorophore; A9–F9, corresponding bright field images. A, limb bud; B, eye; C, heart; D, intestine; E, E9, amnion of a non-transgenic fetus, E0, amnion of
Targeted Integration into the Pig Genome
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dinucleotide sites (Table S2). Due to the relatively short genomic
sequences flanking the integrated transposons and the existing
gaps in the porcine genome sequence, only five out of the 25
identified integration sites could be assigned to their chromosomal
positions; these mapped to porcine chromosomes X, 3, 7, 8, and
13 (Table S2). Four of these were found in intergenic regions of
chromosomes X (Figure S2), 3, 7 and 13, and one integration site
was located within intron 2 of SMARCA5 (SWI/SNF related,
matrix associated actin dependent regulator of chromatin) gene on
chromosome 8 (Table S2; Figure S2).
Embryo transfer of group A zygotes resulted in the birth of 12
piglets at full term, of which two were still born. All piglets were
normally developed, and did not show any abnormalities.
Phenotypically, four of the vital piglets and one of the stillborns
showed strong and homogenous Venus-fluorescence in all surface
areas (Figs. 3A and 3B). Due to a bacterial infection two transgenic
and three non-transgenic animals died shortly after birth. Venus-
fluorescence of skin, tongue, claws and eyes of two vital male pigs
(unique ear tag numbers #503 and #505) did not change over a
period of .12 months, and did not compromise growth,
behaviour or reproductive parameters. PCR genotyping con-
firmed that all phenotypically positive animals carried the Venus-
transposon, but were negative for SB100X–sequences (Fig. 3C).
Two of the piglets (lane 7 in Fig. 3C and right panel) were also
positive for backbone sequences of the Venus-transposon-plasmid.
However, the other animals did not carry backbone sequences
(Figure S3). Monomeric copy numbers of 3, 2 and 1 were found in
ear tag biopsies of the transgenic piglets, respectively (Fig. 3 D). A
molecular analysis of the founder boars#503 and#505, however,
suggested that albeit the analyzed tissue biopsies (ear biopsy and
sperm) are transgenic, the integration sites seem to differ between
tissues (Fig. 3E).
To test germline transmission potential of transgenic founders,
wildtype sows were inseminated with semen from boar #503, and
a total of 18 normally developed F1-fetuses were recovered from
three sacrificed sows. Sixteen F1-fetuses were Venus-positive and
showed a clear grading of fluorescence intensities (Figs. 4A and
4B), whereas two fetuses were fluorescence-negative. Flow
cytometric analysis of fetal cell cultures derived from 5 of the
positive F1-fetuses revealed that their fluorescence intensities split
into two separate classes (Fig. 4C). The more strongly fluorescent
fibroblasts had approximately double the intensity of fluorescence
compared to the weaker ones. Southern blotting suggested that the
weakly fluorescent fetuses carried one Venus-transposon copy,
whereas the strongly fluorescent fetuses carried two transposon
copies (Fig. 4E). Ubiquitous expression of Venus-transcripts was
shown by Northern blotting (Fig. 4D), albeit some variability of
transcript levels can be detected in different organs. One F1 litter
was delivered at term and 8 healthy piglets were born, of which 6
were transgenic and Venus-expressing (Table S1 and Video S1).
Together the data indicate (i) SB-catalyzed integration, (ii)
germline transmission of chromosomally integrated transposons,
(iii) segregation of the transposon integrations and (iv) copy
number dependent fluorescence in F1 offspring.
The Venus-transposon contains heterologous loxP sites (Figure
S1), which should allow targeted exchange of the Venus transgene
cassette against a transgene of choice by transient expression of
Cre recombinase. Thus, transposon-tagged loci can be retargeted
by recombinase-mediated cassette exchange (RMCE) to site-
specifically integrate any transgene of interest in a pretested locus.
In a proof-of-principle experiment, cultured cells isolated of fetus
#37-5, carrying a single Venus-transposon, were co-electroporated
with a floxed CAGGS-mCherry plasmid and a Cre expression
plasmid (Figs. 5 and 6A). Five days after electroporation,
individual cells were identified, which were mCherry positive, but
Venus-negative (Fig. 5). A total of nine clones were isolated with the
expected phenotype suggesting an RMCE frequency of 0.009% in
pig fibroblasts. The mCherry-positive cells were used as donor cells
in a SCNT experiment and a total of 100 reconstructed embryos
were transferred to one recipient, which was sacrificed at day 30
after embryo transfer. A total of 12 normally developed fetuses
were recovered, all showed specific mCherry fluorescence (Figs. 6B
and 6C), but no Venus fluorescence (Fig. 6D), and a lack of the Cre
expression cassette (not shown). Sequencing from both sides of the
flanking genomic DNAs isolated from six fetuses confirmed the
correct RMCE recombination events (Fig. 6E).
Discussion
In this work we established the use of the Sleeping Beauty
transposon system for the generation of germline competent
transgenic pigs by cytoplasmic plasmid injection (CPI) into porcine
zygotes. An overall transgenic frequency of 6.8% per injected
zygotes was achieved, corresponding to 57% and 42% transgenic
frequencies in fetuses and born piglets per litter, respectively. The
use of the SB transposon system for porcine transgenesis has been
explored to some extent by other investigators; e.g. by generating
primary transposition events and antibiotic selection in fibroblasts
that were later used for SCNT [34,35], or transgenesis was
assessed early at blastocyst stage, thereby precluding analysis of
transgene expression and germline transmission in founders [35].
Thus, to our knowledge, our work represents the first report on the
generation of germline-competent porcine founders by direct
microinjection of simple transposon constructs into zygotes. Two
of the founders were found to carry a single integrated transposon
in their genome. The other founders carried multiple monomeric
insertions (2–10), which segregate in the F1 generation. Thus a
founder with 3 monomeric insertions can be bred to yield 3
independent transgenic lines, each carrying a single and unique
transposon integration. Considering the necessary elaborative
resources associated with transgenesis in the pig, this might help to
reduce costs and to decrease animal numbers.
In addition, primary fibroblasts of animals carrying a single
transposon integration were used for targeted transgenesis by
RMCE, and animals were successfully reconstituted from the
targeted fibroblasts by SCNT, demonstrating the feasibility of an
experimental pipeline of targeted transgenesis into transposon-
tagged genomic loci (Fig. 7).
Mechanistically, the classic methods of porcine transgenesis by
pronuclear injection and SCNT rely on the cellular repair
machinery, which becomes activated by spontaneous DNA
double strand breaks (DSB) introduced randomly in the genome
a transgenic fetus; F, mesonephros. G) Flow cytometric determination of Venus-fluorescence. Black line represents wildtype fibroblasts, blue and red
lines, non-transgenic fibroblasts from fetuses #37-1 and #40-1. H) Flow cytometry of Venus-transposon transgenic fibroblasts. Red, blue, green and
purple lines, fibroblasts from fetuses #37-2, #37-3, #37-4 and #37-5, respectively. The difference of fluorescence intensities between wildtype (G)
and transgenic fibroblasts was so great that the transgenic fibroblasts were measured with reduced gain settings. Fibroblasts of #37-3 (blue) were
mosaic, approximately 50% of the cells displayed a reduced fluorescence. I) Southern blot of fetal fibroblasts. M, molecular size marker; wt, wild type
DNA; #37-1 to #37-5, fetal IDs; c, positive control: Venus plasmid digested with NcoI. The NcoI digest produces a constant fragment of 1.4 kb and a
variable fragment .1.4 kb.
doi:10.1371/journal.pone.0023573.g002
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by physical and chemical damage of the chromosomes. At a low
frequency, foreign DNA may erroneously become integrated
into a DSB by the non-homologous end joining pathway [37–
39]. However, since roughly 70% of higher genomes consist of
repetitive elements (telomeres, centromeres, SINEs and LINEs)
and other non-transcribed chromosomal structures [38,39], the
majority of DSB-mediated integrations will occur in transcrip-
tionally inactive chromosomal regions. In addition, the preferred
substrate for the non-homologous end joining pathway is
linearized DNA and, as a consequence, integration of con-
catemerized gene constructs is commonly observed [37].
Extensive screening of numerous founder animals is currently
the only possibility to identify animals with single-copy
integrations and the desired expression pattern. The pre-
screening of transfected nuclear donor cells in SCNT experi-
ments for transgene and/or selection marker expression is not
informative in most cases, since compaction and methylation of
genomic DNA change dramatically in cultured cells and the
commonly used fibroblasts do not transcribe certain tissue-
specific promoters [5,18].
In contrast, SB transposition in microinjected porcine zygotes
resulted in genomic integrations of monomeric units of
transgenes into the pig genome. Single units of expression
cassettes are presumably less prone to transgene silencing than
the concatemeric insertions created by classical methods.
Indeed, all genotypically transgenic animals (F0 and F1) were
also phenotypically positive with no evidence of gene silencing or
variegated transgene expression [20,21]. Our results corroborate
and generalize recent data of SB100X transgenesis in rodents
[33,40], and supports the hypothesis that SB100X-catalyzed
DNA integrations preferentially occur in accessible euchromatic
regions. Even after long-term observation (more than 12
months), no changes in transgene expression were found in the
transgenic pigs, indicating that no age-related silencing of the
transgene occurred. Germline transmission and segregation of
the Venus-tagged transposon was shown by breeding and
recovery of F1-fetuses and the birth of healthy piglets. Upon
germline transmission, a clear copy number-dependent fluores-
cence intensity was found in F1-fetuses, indicating that most
insertion sites are located in transcriptionally permissive domains
of the genome [41]. In line with these observations, Grabundzija
et al. found that transposon insertions delivered by the SB system
only rarely (,4% of all insertions) undergo silencing in HeLa
cells [41]. Furthermore, stable transgene expression observed in
.200 independent insertions in that study suggests that SB
rarely targets heterochromatic chromosomal regions for inser-
tion, and that it is unlikely that certain sequence motifs in the
transposon vector are recognized by mediators of silencing in the
cell [41].
Transposition-mediated transgene integration is somewhat
analogous to viral transduction by injection of the viruses into
the subzonal space of a zygote [42,43], which results in high ratios
of transgenic rodents and farm animals. In this setting, a viral
integrase catalyzes integration into the genome; it has been shown
that lentiviruses prefer exonic regions of transcribed genes for
integration [44,45]. Thus, an increased risk of insertional
Figure 3. Persistent transgene expression in transposon-
transgenic pigs. A) Transgenic boar (#505) viewed under specific
excitation from side and front at the age of 2 months playing with an
auto-fluorescent toy ball (left). B) Wildtype boar (left) and transgenic
boar (#503, right, 8 months of age) photographed side-by-side under a
light source with specific excitation of the Venus fluorophore. The
animals are separated by a fence visible in the middle of the image. Blue
appearance of wildtype animal is due to reflected and scattered
excitation light. C) PCR genotyping of ear biopsies of born piglets for
the presence of Venus, plasmid backbone; SB100X transposase, and
control amplicons [poly(A) polymerase, POL(A)]. M, size marker, lane 1
(#505), lane 2 (#503), lanes 3–11 littermates (no 3-11); wt, wildtype pig
sample. Lane 7 and lane 8 correspond to deceased piglets with Venus-
fluorescence. Right, genotyping of different organs from stillborn piglet
(no 12) with Venus fluorescence: M, size marker; 1, ear; 2, heart, 3,
muscle; 4, spleen; 5, kidney; 6, liver, 7, no template. D) Southern blot of
transgenic piglets. Genomic DNA was isolated from ear biopsies, NcoI
digested and blotted with the Venus probe. M, molecular size marker;
wt, wildtype; 1–5, genomic DNA from transgenic piglets; c, Venus
plasmid control. E) Analysis of cell chimerism; wild type (wt_e and wt_s)
and transgenic boars (#503: 1_e and 1_s; #505: 2_e and 2_s) genomic
DNA from ear biopsies (_e) and spermatozoa (_s) was blotted and
hybridized with the Venus probe. Note the different fragment patterns
between tissues of the founders. In addition genomic DNA from total
fibroblasts of fetus #37-5 (#37-5) and of the cell fraction sorted for
absence of Venus fluorescence was probed (#37-5n).
doi:10.1371/journal.pone.0023573.g003
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mutagenesis is associated with lentiviral transgenesis. The limited
cargo, the preferential integration into exons, the occurrence of
highly mosaic founder animals and transgene silencing limit the
application perspective for lentiviral transgenesis [46]. In contrast,
the SB transposon has a close-to-random insertion profile in
mammalian genomes, and the majority of SB insertions occur
outside of genes. The majority of the integrations that occur within
genes are localized in introns [47–49], and the integration sites in
the pig genome appear to follow the same rules.
The molecular events and timing of transposition in porcine
embryos need to be further investigated. Previous experiments
suggested that CMV promoter-driven marker genes in circular
plasmids are transcribed concomitantly with major embryonic
genome activation [36], which is at the 4-cell stage in porcine
embryos [50]. How the circular plasmids translocate from
cytoplasm to nucleus is currently unclear, a possibility is that
some plasmids enter the nucleus region after nuclear membrane
disassembly during the first cell cycle.
The majority of founder pigs generated here seem to express
Venus homogenously. A molecular analysis of the founder boars
#503 and #505, however, suggested that albeit all analyzed tissue
biopsies (ear skin and sperm) were transgenic, the integration sites
seem to differ between tissues. To clarify, whether this may be due
to late integration events in different blastomeres, or to re-
mobilization of early integrants by the transiently present SB
protein requests a more detailed study. Finally, we demonstrate
targeted transgene integration into genomic sites that are defined
by SB transposon insertions carrying heterospecific loxP sites by
transient expression of Cre recombinase in the presence of a floxed
mCherry construct. Thus, transgene cassettes of interest can be
serially knocked into the exact same position in the genome
allowing comparative gene expression studies. Fibroblasts with
transcriptionally permissive chromosomal loci tagged by SB
transposon insertions can thus be utilized as master clones
amenable to advanced genetic engineering in the pig. In
conclusion, the technology based on cytoplasmic microinjection
of Sleeping Beauty transposon plasmids is a simple and efficient
technique yielding transgenic pigs with germline transmission and
stable transgene expression at efficiencies that improve genome
modifications in the pig, and thus may allow generating better
models for human diseases.
Materials and Methods
Ethics statement
Animals were maintained and handled according to the
German guidelines for animal welfare, and to the German law
regarding genetically modified organisms. The animal experi-
ments were approved by an external ethics committee (Nieder-
sa¨chsisches Landesamt fu¨r Verbraucherschutz und Lebensmittel-
sicherheit, AZ 33.9-42502-04-09/1718).
Figure 4. Segregation of Venus-transposons in F1-fetuses.
Fetuses derived from insemination of a wildtype sow with semen of
transgenic boar #503 were isolated at day 29 p.c., and fluorescence
images were taken under normalized conditions. A) Typical image of a
strongly fluorescent fetus (F1-2), B) Typical image of a weakly
fluorescent fetus (F1-4). The fluorescence intensities correlated with
the transposon copy numbers, as determined by Southern blotting. C)
Flow cytometric measurements of Venus-fluorescence in fibroblasts
derived from F1-fetuses with weak fluorescence intensity: F1-1 (red), F1-
5 (purple), F1-11 (yellow) and strongly fluorescent fetuses: F1-5 (blue)
and F1-9 (green). D) Expression of Venus in different tissues of d29
porcine fetus (F1-3, strongly fluorescent) as determined by Northern
blotting with a Venus-specific probe (top): head (1); carcasse (2);
mesonephros (3); liver (4); heart/lung (5) and control samples from
wildtype pig: heart (6); lung (7); liver (8). In addition, RNAs from wildtype
murine heart (9) and lung (10); and RNAs from Venus-transposon
transgenic murine heart (11) and lung (12) were loaded. Bottom,
reprobed blot with an actin-specific probe. Porcine tissues show organ-
specific splice patterns of actin transcripts [51]. E) Segregation of Venus-
transposons in F1-animals. Genomic DNA from F1-fetuses was analysed
by Southern blot with the Venus-probe. M, size marker; 1–10, genomic
DNA from ten F1 offspring. Black arrow, internal, constant band at
,1.4 kb; blue arrow, external fragment of one integrant; red arrow,
external fragment of the other integrant. 16 and 26 indicate the
deduced transposon copy numbers.
doi:10.1371/journal.pone.0023573.g004
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Animal experimentation: Superovulation, flushing of
zygotes, embryo transfer (ET), recovery of fetuses, sperm
analysis, artificial insemination
Gilts were superovulated by intramuscular injection of 1’000 U
Intergonan/PMSG (96 h before insemination) and 500 U Ovo-
gest/hCG (24 h before insemination) and then artificially
inseminated on day 0. The next day, the animals were slaughtered,
oviducts were excised, flushed with PBS/1% new born calf serum
and zygotes were collected and used for microinjection. 30–40
intact embryos were surgically transferred into the oviduct of a
synchronized recipient. In some cases, pregnant recipients were
sacrificed and fetuses were recovered. Sperm cells were obtained
from wildtype and transgenic boars using a phantom and
immediately diluted in Androhep solution.
Figure 5. Recombinase-mediated cassette exchange in Venus-transposon transgenic fibroblasts. Primary fibroblasts from fetus #37-5
carry a single Venus-transposon. The Venus-transposon includes heterologous loxP sites (see Figure S1). Five day after co-electroporation of a Cre
expression plasmid and an mCherry exchange plasmid, the cells were screened under brightfield (A), Venus-optics (A9) and mCherry optics (A0). The
dashed circle indicates a cell, which presumptively underwent Cre-mediated cassette exchange (mCherry positive and Venus-negative). The arrow
points to a cell with an illegitimate recombination event (mCherry positive and Venus positive). Some round cells (most likely dead cells) are floating in
the medium and are out of the focus plane and thus do not appear in A9or A0. B–B0) Clonal isolation and expansion of Cre-recombined cells.
Importantly, the screening and clonal isolation procedures are based only on fluorescence criteria and no antibiotics selection was applied. C) PCR
confirmation of specific cassette exchange. Batch fibroblasts were analysed 10 days after electroporation. In lanes 1-6, primers specific for the Venus-
transposon (see Fig. 6A for primer positions) were employed (amplicon size 480 bp); in lanes 19–69, primers specific for a successful RMCE event (see
Fig. 6A) were employed, which specifically amplify a 395-bp fragment. Lanes 1–5 correspond to fibroblasts (#37-5) electroporated with no plasmid
(1), with mCherry exchange plasmid (2), with mCherry and Cre plasmids (3), or were untreated (4), or wildtype fibroblast (5). Lane 6 is a negative
control with no template. In lane 39 an amplicon of the expected size for a successful RMCE event is detectable.
doi:10.1371/journal.pone.0023573.g005
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Preparation of ccc-plasmids and cytoplasmic injection
The plasmids pT2/RMCEVenus and pCMV-SB100X were
transformed in XL10 or ER2925 bacteria, respectively. Super-
coiled plasmid DNA was isolated with anion exchange columns
and resuspended in ultrapure water and checked for the absence of
bacterial genomic DNA or endotoxins [36]. The DNA concen-
tration was determined by a NanoDrop photometer; purity and
supercoiled ccc-conformation were verified by gel electrophoresis.
Plasmids were prepared in 10 mM Tris-HCl pH 7.6 and
0.25 mM EDTA pH 8.0, and backfilled in glass injection
capillaries. Individual embryos were fixed by suction to a holding
pipette, while the injection capillary was pushed though Zona
pellucida and cell membrane. Approximately 10 pl of the plasmid
solution was then injected with a pressure of 1 bar into the
cytoplasm using a pressure-controlled Eppendorf transjector 5246
(Eppendorf, Hamburg, Germany). SB100X-mRNA was prepared
as described [33].
Fluorescent microscopy and macroscopic excitation of
Venus fluorochrome
For fluorescence microscopy, a Zeiss Axiovert 35 M microscope
equipped with fluorescence optics for Hoechst 33342, GFP and
rhodamine was used. Alternatively, images were obtained by an
Olympus BX 60 (Olympus, Hamburg, Germany) fluorescence
microscope equipped with a high resolution digital camera
(Olympus DP71).
Genotyping and identification of integration sites
Transposon-genomic DNA junctions were determined using
splinkerette PCR as described earlier [22]. The purified PCR
product was cloned into the pGEM-Teasy vector (Promega,
Madison, USA), and the DNA sequence was determined by
standard sequencing technology (ABI3730XL Applied Biosystems,
Foster City, California). Sequences were analyzed with BLAST at
www.ensembl.org (assessed 24.08.10). Southern blots and PCR
reactions of genomic DNA were done according to standard
procedures. In brief, for Southern blot detection of Venus transposon
copies, the genomic DNA was digested with NcoI. Hybridisation
with a CAGGS-Venus probe (1.4 kb fragment generated by EagI
digest of pT2/RMCE) then resulted in a constant internal fragment
of ,1.4 kb and a variable external fragment of .1.4 kb per
integration (Figure S1). To assess for the presence of random
integrations of the transposon, the genomic DNA was digested with
BamHI. On the transposon plasmid the ITRs are flanked by 2 sites
for BamHI in neighoring sequences. In case of SB100X catalyzed
integrations these BamHI sites are lost. Unspecific integrations
should produce a constant 3.39 kb fragment after hybridization with
the CAGGS-Venus probe (Figure S1). However, no indications of
unspecific integrations were detected (not shown). To assess for
SB100X sequences, the blots were hybridized with a SB100X probe,
generated by labeling the whole plasmid.
Preparation of primary cell culture and FACS
measurements
Primary cells were derived from fetal and adult tissues as described
[21] and cultured in DMEM supplemented with 10% fetal calf
serum and antibiotics. Leukocytes were isolated from EDTA-blood
samples and resuspended in PBS. Flowcytometry analysis of primary
cells, leukocytes and spermatozoa was performed using a FACScan
(BD Bioscience, Heidelberg, Germany) equipped with an argon laser
(488 nm, 15 mW). Samples were diluted to 0.56106 cells/ml and
measured in dublicates acquiring 10 000 cells per sample. Cells with
membrane damage were excluded from the analysis by counter-
staining with propidium iodide (20 mM).
Recombination-mediated cassette exchange (RMCE) in
primary fibroblasts
300 000 fibroblasts (passage 2) isolated from a fetus, which carried
a single floxed Venus-transposon (Figure S1) were co-electroporated
with 200 ng of pCAG-Cre (gift from Dr. C. Cepko via www.
addgene.org) and 500 ng of pUC-RMCE-CAGGSmCherry, carry-
ing a floxed mCherry expression cassette. For electroporation
Figure 6. Recombination-mediated cassette exchange in the pig. A) Schematic depiction of RMCE in transposon-tagged porcine cells. B–D)
Fetus obtained from nuclear transfer of RMCE fibroblasts photographed under brightfield (B), mCherry fluorescence (C) and Venus fluorescence (D)
conditions.
doi:10.1371/journal.pone.0023573.g006
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rectangular pluses of 100 V and 10 ms (Biorad, GenePulserxcell,
Mu¨nchen, Germany) were applied and the cells were seeded in Petri-
dishes. Cell clones which only expressed mCherry, but were Venus-
negative, were subcloned by cloning cylinders.
Northern blot
Total RNA was extracted from tissues using TRIsure Reagent
(TRIsure; BIOLINE GmbH, Luckenwalde, Germany) according
to standard procedures. RNA quality was evaluated with a 2100
Bioanalyzer (RNA nano chip, Agilent Technologies, Waldbronn,
Germany). Northern blotting was performed as described [24] and
blots were hybridized overnight (68uC) with DIG labeled probes
complementary to EGFP (900 bp) and subsequently to ACTB.
Hybridization signals were detected by chemiluminescence (Fusion
FX, Vilber Lourmat, Eberhardzell, Germany).
Somatic nuclear transfer of RMCE cells
Somatic nuclear transfer was performed as described recently [51].
In brief, oocytes were enucleated by removing the first polar body
along with the adjacent cytoplasm containing the metaphase plate. A
fibroblast from the RMCE cells was placed in the perivitelline space
in close contact with the oocyte membrane. Cell membran fusion was
induced in Ca2+-free medium (0.25 mol/l sorbitol, 0.5 mmol/l Mg-
acetate, 0.1% BSA) by a single electrical pulse of 1.1 kV/cm for
100 ms (Eppendorf Multiporator, Eppendorf, Germany). The
reconstructed embryos were activated in an electrical field of
1.0 kV/cm for 45 ms in SOR2 activation medium (0.25 mol/l
sorbitol, 0.1 mmol/l Ca-acetate, 0.5 mmol/l Mg-acetate, 0.1% BSA)
followed by incubation with 2 mmol/l 6-dimethylaminopurine
(DMAP, Sigma-Aldrich, Germany) in NCSU23 medium for 3 h
prior to embryo transfer to recipients. 100 reconstructed embryos
were surgically transferred into the oviducts of one synchonized
peripubertal German landrace recipients via mid ventral laparatomy
under general anaesthesia. A pregnancy was confirmed by ultrasound
scanning on day 25 of gestation, and the recipient was sacrificed and
fetuses were recovered at day 30.
Supporting Information
Figure S1 Sleeping beauty plasmids. The non-autonomous
transposon components pCMV-SB100X (Cytomegalovirus pro-
Figure 7. Schematic depiction of targeted transgenes in the pig genome. First, SB-catalyzed transgenesis was employed to tag genomic loci,
which are suitable for expression. Founder animals with appropriate expression levels and only one transposon integration were selected and used to
derive primary cell cultures. Then, the reporter construct (Venus) was specifically exchanged against a gene of interest (here mCherry) via Cre
recombinase and heterospecific loxP sites (blue triangles). Cells which underwent successful RMCE events were isolated by screening for loss of Venus
fluorescence and gain of mCherry fluorescence, and were used in somatic cell nuclear transfer to establish cloned piglets, with targeted mCherry
integration into a pre-tested genomic locus.
doi:10.1371/journal.pone.0023573.g007
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moter (CMV) driven SB100X-cDNA) and pT2/VenusRMCE
(CAGGS promoter driven Venus-cDNA flanked by SB internal
terminal repeats (ITR)) are co-injection into the cytoplasm of
porcine zygotes. After expression of the SB100X plasmid, the
SB100X transposase catalyzes transposition of the Venus trans-
poson to a chromosome, thereby creating a stably transgenic
status. Backbone sequences of the Venus-plasmid and the
SB100X-plasmid are lost or become degraded over time. In the
absence of SB, the Venus transposon is fixed at a certain
integration site. Hatched bar indicate the Venus-specific probe for
Southern blotting, genomic DNA was digested with NcoI, thus
labelling of an internal fragment of ,1.4 kb and an external
fragment(s) of .1.4 kb is expected. For the detection of unspecific
integrated Venus constructs, the genomic DNA was digested with
BamHI. The BamHI sites flanking the Venus transposon on the
pTE/VenusRMCE plasmid are lost during specific transposition.
Backbone and SB100X-specific probes were used to assay for
presence of these sequences by Southern blotting. Arrows indicate
the positions of primers used for PCR genotyping. Blue triangles
stand for heterospecific loxP sites. Drawing is not at scale.
(TIF)
Figure S2 Alignment of identified integration site to
porcine chromosome X. Exemplarily, the integration sites on
the porcine chromosome X is depicted (No. 3 clone 37_2_2 in
Table S2). The integration site was aligned to the porcine genome
by the ensembl resource (www.ensembl.org). The displayed area
covers a 20 kb stretch of chromosomal DNA, and the location of
transposon integration (red bar in line labeled BLAT/BLAST
hits), as well as the positions of annotated or predicted genes,
LTRs, retrotransposal elements, and G/C ratio are shown.
(TIF)
Figure S3 Southern blot hybridized with backbone
probe. The blot shown in Fig. 2E was stripped and hybridized
with a backbone probe of pT2/VenusRMCE. The backbone
probe was generated by BamHI digest of pT2/VenusRMCE and
isolation of a 2.8 kb fragment. A randomly integrated backbone
sequence should result in a .2.8 kb fragment after Southern
blotting.
(TIF)
Table S1 List of transgenic founders and F1-offspring.
(DOC)
Table S2 Transposon integration sites in the pig
genome.
(DOC)
Video S1 F1-litter of Venus-fluorescent piglets. Breeding
of founder boar #503 with a wild-type sow resulted in a litter of
eight piglets. Founder #503 carries three single copy transposon
integrations. The calculated ratio of transgenic offspring is 87.5%
(permutations of the three integrants), if the integration sites
represent indeed single copy events and are independently
inherited. The piglets are shown under illumination with (i)
normal light, (ii) blue light excitation and (iii) blue light excitation
and emission filter. Note the different fluorescence intensities at
specific excitation (condition iii). The fluorescence intensities
directly correlated with the number of transposon copies as
determined by Southern blotting. The two non-transgenic piglets
are only vaguely visible under fluorescence recording.
(WMV)
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